artemether + lumefantrine
Commercial- Indications
- Malaria
Company intelligence / Profile preview
Schwitz Biotech manufactures and exports a wide range of pharmaceutical formulations including antibiotics, antacids, injectables, nutraceuticals and herbal products. The company operates globally with WHO-GMP certified manufacturing facilities and supplies to multiple countries in Africa, CIS region and Central America. No clinical trial results are reported as the company focuses on generic/commercial products rather than novel drug development.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Schwitz Biotech.